NVCR – novocure limited - ordinary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

NVCR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/12

07:17 am

nvcr

NovoCure (NASDAQ:NVCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Medium Report

NovoCure (NASDAQ:NVCR) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

1/15

09:19 am

nvcr

NovoCure (NASDAQ:NVCR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.

Low Report

NovoCure (NASDAQ:NVCR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.

Report

1/15

09:19 am

nvcr

NovoCure (NASDAQ:NVCR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.

Low Report

NovoCure (NASDAQ:NVCR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.

Report

1/15

09:02 am

nvcr

Rating for NVCR

Low Report

Rating for NVCR

Report

1/15

09:02 am

nvcr

Rating for NVCR

Low Report

Rating for NVCR

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.